z-logo
open-access-imgOpen Access
Exogenous and Endogenous TLR Ligands Activate Anti-Chromatin and Polyreactive B Cells
Author(s) -
Michele L. Fields,
Michele H. Metzgar,
Brian D. Hondowicz,
SunAh Kang,
Shawn T. Alexander,
Kristin D. Hazard,
Alice Hsu,
Yangzhu Du,
Eline T. Luning Prak,
Marc Monestier,
Jan Erikson
Publication year - 2006
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.176.11.6491
Subject(s) - tlr9 , chromatin , biology , microbiology and biotechnology , breakpoint cluster region , b cell , b cell receptor , transgene , receptor , antibody , immunology , gene , gene expression , genetics , dna methylation
Autoreactive B cells may become activated in a T-independent manner via synergistic engagement of the BCR and TLRs. Using the VH3H9 Ig H chain transgene to track anti-chromatin B cells, we demonstrate that VH3H9/Vlambda1 anti-chromatin B cells proliferate in response to stimulatory oligodeoxynucleotides containing CpG motifs, suggesting that these autoreactive B cells are responsive to TLR9 signaling. Strikingly, some VH3H9 B cells, but not the well-characterized VH3H9/Vlambda1 B cells, proliferate spontaneously in culture medium. This proliferation is blocked by inhibitory CpG oligodeoxynucleotides, implicating the TLR9 (or possibly TLR7) pathway. Most hybridomas generated from the proliferating cells are polyreactive, and one exhibits binding to nuclear Ags but not to the other Ags tested. Thus, B cells carrying autoreactive and/or polyreactive specificities may be susceptible to T cell-independent activation via dual engagement of the BCR and TLRs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom